TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18616432

Group type: COMPARATOR
Intervention: Morphine (only)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Morphine and hydromorphone
Number of subjects: 32
Study: 15780537

Group type: EXPERIMENTAL
Intervention: Intranasal 17beta‐estradiol treatment (300 microg once daily)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 26
Study: 11975863

Group type: EXPERIMENTAL
Intervention: DHEA (300 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: DHEA and Placebo
Number of subjects: 16
Study: 10188125

Group type: EXPERIMENTAL
Intervention: Stereolithographic biomodelling (biomodels)
Number of subjects: 45
Study: 8554932

Group type: EXPERIMENTAL
Intervention: 5 mg salbutamol via nebuliser
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 1824806

Group type: EXPERIMENTAL
Intervention: Doxazosin (mean dose 4.35 ± 0.2 mg/day)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 17
Study: 6620532

Group type: COMPARATOR
Intervention: Group C (no premedication)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Group D (diazepam 0.2mg/kg i.m.)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Group M (meperidine 1mg/kg i.m.)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Group A (atropine 0.01mg/kg i.m.)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Group AD (atropine 0.01mg/kg and diazepam 0.2mg/kg i.m.)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Group AM (atropine 0.01mg/kg and meperidine 1mg/kg i.m.)
Number of subjects: 63
Study: 31072841

Group type: EXPERIMENTAL
Intervention: Exercise therapy plus early reconstructive surgery
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Exercise therapy plus delayed reconstructive surgery, if needed
Number of subjects: 100
Study: 29768643

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) - Full squat with low-load (45-60% 1RM) and low-volume (2-3 sets and 4-6 repetitions)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Combined Resistance Training and Loaded Change of Direction (S+CDG) - Same RT program combined with loaded CD (2-5 sets of 10 s)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 34
Study: 26411271

Group type: EXPERIMENTAL
Intervention: Cardio neuroablation (CNA) via radiofrequency catheter ablation (RFCA) targeting the three main paracardiac ganglia around the heart.
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Cardio neuroablation (CNA) via RFCA targeting the three main paracardiac ganglia around the heart.
Number of subjects: 22

Group type: COMPARATOR
Intervention: Atropine infusion on admission.
Number of subjects: 22
Study: 23269469

Group type: EXPERIMENTAL
Intervention: Acoustical measures
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Organizational measures
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 89
Study: 22335998

Group type: EXPERIMENTAL
Intervention: Balance training
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Weight training
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 18
Study: 20635236

Group type: EXPERIMENTAL
Intervention: 40-min live group music programme, three times a week for eight weeks
Number of subjects: 47

Group type: COMPARATOR
Intervention: Reading control group
Number of subjects: 47
Study: 17257444

Group type: EXPERIMENTAL
Intervention: ICU-based medical emergency team (MET) service
Number of subjects: 2183

Group type: COMPARATOR
Intervention: Control period (no MET)
Number of subjects: 2183
Study: 16380589

Group type: EXPERIMENTAL
Intervention: Oral amiodarone (10 mg/kg daily) administered 6 days prior to surgery through 6 days after surgery (13 days)
Number of subjects: 601

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 601

Group type: EXPERIMENTAL
Intervention: Oral amiodarone
Number of subjects: 601
Study: 12216049

Group type: EXPERIMENTAL
Intervention: Levalbuterol
Number of subjects: 147
Study: 11475741

Group type: EXPERIMENTAL
Intervention: Artificial Shexiang Baoxin Pill (SXBXP)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Natural Shexiang Baoxin Pill (SXBXP)
Number of subjects: 225
Study: 7649426

Group type: EXPERIMENTAL
Intervention: Patients with family history of thrombosis
Number of subjects: 73

Group type: COMPARATOR
Intervention: Patients with family history of MI
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Whole population of MI patients
Number of subjects: 73
Study: 2668784

Group type: EXPERIMENTAL
Intervention: Azathioprine (AZ) with methylprednisolone (MP) for the first 36 weeks
Number of subjects: 98

Group type: COMPARATOR
Intervention: Azathioprine (AZ)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Azathioprine (AZ) with methylprednisolone (MP)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo (for both drugs)
Number of subjects: 98
Study: 711895

Group type: EXPERIMENTAL
Intervention: Marihuana in a threat environment
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Marihuana in a no-threat environment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo in a threat environment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo in a no-threat environment
Number of subjects: 60
Study: 31845535

Group type: EXPERIMENTAL
Intervention: Incremental Shuttle Walk Test (ISWT)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Timed Up and Go (TUAG)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Sit-to-Stand Transfers in 60 seconds (STS-60)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Duke's Activity Status Index (DASI)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Hospital Anxiety and Depression Scale (HAD) - Anxiety Subscale
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Hospital Anxiety and Depression Scale (HAD) - Depression Subscale
Number of subjects: 40
Study: 29236554

Group type: EXPERIMENTAL
Intervention: Vicarious Self-Affirmation (VSA) condition
Number of subjects: 225

Group type: COMPARATOR
Intervention: Vicarious Control condition
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Traditional value affirmation
Number of subjects: 225
Study: 28816728

Group type: EXPERIMENTAL
Intervention: OPTI‐FREE PureMoist with ETA lenses
Number of subjects: 791

Group type: COMPARATOR
Intervention: ETA lenses
Number of subjects: 791

Group type: COMPARATOR
Intervention: SENO lenses
Number of subjects: 791

Group type: COMPARATOR
Intervention: GALY lenses
Number of subjects: 791

Group type: COMPARATOR
Intervention: All lens types with any of the four care solutions
Number of subjects: 791
Study: 26005839

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 223

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) in Veterans
Number of subjects: 223
Study: 23670850

Group type: EXPERIMENTAL
Intervention: At-risk overweight/obese (ARO) women
Number of subjects: 0

Group type: COMPARATOR
Intervention: Metabolically benign overweight/obese (MBO) women
Number of subjects: 0
Study: 21375950

Group type: EXPERIMENTAL
Intervention: First donning experience of life jackets
Number of subjects: 56

Group type: COMPARATOR
Intervention: Subsequent donning experiences of life jackets
Number of subjects: 56
Study: 18191265

Group type: EXPERIMENTAL
Intervention: Concomitant chemo radiation treatment
Number of subjects: 119
Study: 16314075

Group type: EXPERIMENTAL
Intervention: Topical anesthesia
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Topical anesthesia first
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo first
Number of subjects: 20
Study: 12637115

Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg
Number of subjects: 1087

Group type: COMPARATOR
Intervention: Simvastatin 20 mg
Number of subjects: 1087
Study: 10850611

Group type: EXPERIMENTAL
Intervention: Mycophenolate Mofetil (MMF)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Azathioprine (AZA)
Number of subjects: 57
Study: 9093249

Group type: EXPERIMENTAL
Intervention: Transcervical resection of the endometrium (TCRE)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Hysterectomy
Number of subjects: 202
Study: 7681769

Group type: EXPERIMENTAL
Intervention: Synthetic porcine galanin IV, 500 micrograms in 100 mL
Number of subjects: 5

Group type: COMPARATOR
Intervention: Saline IV, 100 mL
Number of subjects: 5
Study: 3486264

Group type: EXPERIMENTAL
Intervention: Human surfactant treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional mechanical ventilation
Number of subjects: 0
Study: 31495382

Group type: EXPERIMENTAL
Intervention: Standard dose of alcohol (one standard drink)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: g/kg dosing of alcohol (controlling for gender)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115
Study: 30047784

Group type: EXPERIMENTAL
Intervention: Intensive psychosocial intervention
Number of subjects: 270

Group type: COMPARATOR
Intervention: Brief psychoeducation with collaborative care
Number of subjects: 270
Study: 26608256

Group type: EXPERIMENTAL
Intervention: Liraglutide (1.8 mg daily)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 24992552

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) nasal aerosol at 320 μg once daily
Number of subjects: 529

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 529
Study: 23091097

Group type: EXPERIMENTAL
Intervention: Chlorambucil or fludarabine with and without cyclophosphamide
Number of subjects: 224
Study: 20506228

Group type: EXPERIMENTAL
Intervention: TR band
Number of subjects: 790

Group type: COMPARATOR
Intervention: Radistop
Number of subjects: 790

Group type: EXPERIMENTAL
Intervention: Both devices
Number of subjects: 790
Study: 18548866

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15741004

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Both treatments (Amitriptyline and Fluvoxamine)
Number of subjects: 38
Study: 12747810

Group type: EXPERIMENTAL
Intervention: Paroxetine 20 mg per day
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 10561206

Group type: EXPERIMENTAL
Intervention: Low-dose chemotherapy (doxorubicin 20 mg/m(2), vincristine 1 mg/m(2) on day 1; cyclophosphamide 300 mg/m(2); methotrexate 25 mg/m(2); fluorouracil 600 mg/m(2) on days 29 and 36) plus tamoxifen 20 mg orally for 2 years
Number of subjects: 613

Group type: COMPARATOR
Intervention: Tamoxifen 20 mg orally for 2 years
Number of subjects: 613

Group type: COMPARATOR
Intervention: No treatment (terminated group)
Number of subjects: 613
Study: 8568142

Group type: EXPERIMENTAL
Intervention: Skin prick tests
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Patch tests
Number of subjects: 183

Group type: COMPARATOR
Intervention: Oral cow milk challenges
Number of subjects: 183
Study: 1990041

Group type: EXPERIMENTAL
Intervention: Cefaclor
Number of subjects: 93

Group type: COMPARATOR
Intervention: Penicillin
Number of subjects: 93
Study: 6885683

Group type: EXPERIMENTAL
Intervention: Amoxycillin 3g bd
Number of subjects: 207

Group type: COMPARATOR
Intervention: Amoxycillin 250 mg tds
Number of subjects: 207
Study: 31962329

Group type: EXPERIMENTAL
Intervention: Traditional medicine-based diet and lifestyle recommendations for at least 3 months
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Traditional medicine-based diet and lifestyle recommendations
Number of subjects: 180
Study: 31282333

Group type: EXPERIMENTAL
Intervention: Left nostril (Group A)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Right nostril (Group B)
Number of subjects: 120
Study: 28300045

Group type: EXPERIMENTAL
Intervention: Triphala churna
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 60
Study: 25572874

Group type: EXPERIMENTAL
Intervention: Microfluidic device (n = 58)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Standard microdrop dish (n = 60)
Number of subjects: 118
Study: 23487543

Group type: EXPERIMENTAL
Intervention: Response criteria based on NYHA class reduction ≥ 1
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Response criteria based on reduction in left ventricular end‐systolic index by > 15%
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Clinical response criteria
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Echocardiographic response criteria
Number of subjects: 97
Study: 21656526

Group type: EXPERIMENTAL
Intervention: Minimally invasive distal gastrectomy (MIDG)
Number of subjects: 666

Group type: COMPARATOR
Intervention: Open distal gastrectomy (ODG)
Number of subjects: 666
Study: 19293290

Group type: EXPERIMENTAL
Intervention: Goal Management Training
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Identity Oriented Goal Training
Number of subjects: 34

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 34
Study: 17436179

Group type: EXPERIMENTAL
Intervention: In-home exercise program
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Inpatient exercise program
Number of subjects: 10
Study: 15603060

Group type: EXPERIMENTAL
Intervention: Young template representing the pigment O‐beta‐glucoside of 3‐hydroxykynurenine in young eyes.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aged template representing pigments accumulating in the lens with age.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Analysis of reflectance spectra in pseudophakes.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Age effects on photoreceptor reflectivity.
Number of subjects: 0
Study: 11687542

Group type: EXPERIMENTAL
Intervention: Latanoprost (0.005%, 30 microl)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Indomethacin (5 mg/kg) pretreatment
Number of subjects: 0
Study: 9149075

Group type: EXPERIMENTAL
Intervention: Maximal voluntary isometric contraction (MVIC) testing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Multiple clinical evaluators in a single site
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rigorous quality assurance standards and monitoring of clinical evaluators
Number of subjects: 0
Study: 8190478

Group type: EXPERIMENTAL
Intervention: 0.3% ciprofloxacin
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 0.3% norfloxacin
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 0.3% ofloxacin
Number of subjects: 32
Study: 3070369

Group type: EXPERIMENTAL
Intervention: Indomethacin (0.2 mg/kg, 3 times p.o. in 12 h intervals starting on the 3rd day of life)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (22 VLBWI with comparable weight 1250 ± 154 g, gestational age 28.4 ± 1 weeks)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Indomethacin treatment
Number of subjects: 19
Study: 30511107

Group type: EXPERIMENTAL
Intervention: Autologous CIK cells transfusion combined with radiochemotherapy
Number of subjects: 89

Group type: COMPARATOR
Intervention: Radiochemotherapy
Number of subjects: 89
Study: 28532866

Group type: EXPERIMENTAL
Intervention: Pilates-inspired exercise training (2 times/week, 60 min/session)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 40
Study: 26118755

Group type: EXPERIMENTAL
Intervention: Stepped care and monitoring of symptoms
Number of subjects: 46

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 46
Study: 22672773

Group type: EXPERIMENTAL
Intervention: VAC(®) therapy
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sorbalgon(®) therapy
Number of subjects: 10
Study: 21584935

Group type: COMPARATOR
Intervention: Propofol alone (Group P)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Propofol-ketamine combination (Group K)
Number of subjects: 121
Study: 18077045

Group type: EXPERIMENTAL
Intervention: Probiotic lactobacilli-containing yogurt
Number of subjects: 15
Study: 17257456

Group type: EXPERIMENTAL
Intervention: Cefdinir 300 mg BID for 10 days
Number of subjects: 391

Group type: COMPARATOR
Intervention: Cephalexin 250 mg QID for 10 days
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: Cefdinir
Number of subjects: 391

Group type: COMPARATOR
Intervention: Cephalexin
Number of subjects: 391
Study: 15147939

Group type: EXPERIMENTAL
Intervention: Discrimination of number
Number of subjects: 2

Group type: COMPARATOR
Intervention: Cumulative surface area representation
Number of subjects: 2
Study: 11226644

Group type: EXPERIMENTAL
Intervention: HIV positive patients with burns
Number of subjects: 33

Group type: COMPARATOR
Intervention: HIV negative controls
Number of subjects: 33
Study: 9832481

Group type: EXPERIMENTAL
Intervention: PTCA (n=44)
Number of subjects: 83

Group type: COMPARATOR
Intervention: no-PTCA (n=39)
Number of subjects: 83
Study: 8125554

Group type: EXPERIMENTAL
Intervention: Digitalis
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 2911834

Group type: EXPERIMENTAL
Intervention: Chlorthalidone
Number of subjects: 551

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 551
Study: 15029134

Group type: EXPERIMENTAL
Intervention: Diet with decreased sodium content
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aerobic physical exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of diet and aerobic exercise
Number of subjects: 0
Study: 31648607

Group type: EXPERIMENTAL
Intervention: Self-control (SC)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Self-control with load (SCL)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Yoked (YK)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Yoked with load (YKL)
Number of subjects: 48
Study: 30866926

Group type: EXPERIMENTAL
Intervention: Consultation for chronic cough
Number of subjects: 922

Group type: EXPERIMENTAL
Intervention: Stigma
Number of subjects: 922
Study: 26864888

Group type: EXPERIMENTAL
Intervention: Psychologically informed practice (PIP) intervention for 12 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison group without PIP intervention
Number of subjects: 0
Study: 25374138

Group type: EXPERIMENTAL
Intervention: Nicardipine (20 μg/kg)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Esmolol (0.5 mg/kg)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control (5 ml saline)
Number of subjects: 82
Study: 24620386

Group type: EXPERIMENTAL
Intervention: Xuebijing injection (100 mL added to 0.9% saline for 3 days preoperatively)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no Xuebijing injection)
Number of subjects: 60
Study: 21933609

Group type: EXPERIMENTAL
Intervention: Benazepril (10 mg per day for at least 3 days before procedure)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Control group (no benazepril)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Benazepril group
Number of subjects: 114

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 114
Study: 19330581

Group type: EXPERIMENTAL
Intervention: Imagery Rehearsal Therapy (IRT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Waiting-list (Control)
Number of subjects: 20
Study: 16813587

Group type: COMPARATOR
Intervention: Short-course radiotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemo-radiotherapy (CRT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination chemotherapy with oxaliplatin and irinotecan
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Targeted agents bevacizumab and cetuximab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neo-adjuvant chemotherapy prior to preoperative CRT
Number of subjects: 0
Study: 14970007

Group type: EXPERIMENTAL
Intervention: Hypoglycemic clamps in Controls
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Hypoglycemic clamps in ADX
Number of subjects: 19
Study: 11437096

Group type: EXPERIMENTAL
Intervention: 148 MBq 89Sr i.v. (Group A)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 1406 MBq 186Re‐HEDP i.v. (Group B)
Number of subjects: 50
Study: 9250454

Group type: EXPERIMENTAL
Intervention: Lys(B28), Pro(B29) human insulin analog (insulin lispro)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Human regular insulin
Number of subjects: 12
Study: 8252676

Group type: EXPERIMENTAL
Intervention: 15 J biphasic shocks at axillary location
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 15 J biphasic shocks at thoracic electrode locations
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Mean single-shock DFT
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 15 J shocks at axillary location
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 10 J shocks at axillary location
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Low-energy endocardial defibrillation at 10 J
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 5 J shocks
Number of subjects: 14
Study: 3613693

Group type: EXPERIMENTAL
Intervention: Buspirone 25 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Buspirone 50 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Buspirone 100 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sulpiride 200 mg
Number of subjects: 10
Study: 30761535

Group type: EXPERIMENTAL
Intervention: Mortality Salience (MS) condition
Number of subjects: 450

Group type: COMPARATOR
Intervention: Frightening condition
Number of subjects: 450

Group type: COMPARATOR
Intervention: Neutral condition
Number of subjects: 450
Study: 30628540

Group type: EXPERIMENTAL
Intervention: Continuous saline bladder irrigation (CSBI)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Single immediate instillation of mitomycin C (SI-MMC)
Number of subjects: 151
Study: 28639862

Group type: EXPERIMENTAL
Intervention: Weightlifting training session at 08:00
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Weightlifting training session at 14:00
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Weightlifting training session at 18:00
Number of subjects: 9
Study: 26057685

Group type: EXPERIMENTAL
Intervention: Revised Youth Fit 4 Life protocol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Original Youth Fit For Life treatment
Number of subjects: 0
Study: 23022645

Group type: EXPERIMENTAL
Intervention: Early endoscopic surgery (<1 week after diagnosis)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Delayed endoscopic surgery (>6 months after diagnosis)
Number of subjects: 100